Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.67 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 5/20 | 0.46 |
| ▸ | PPARD | Q03181 | 5/20 | 0.46 |
| ▸ | PPARA | Q07869 | 5/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20476 | 1.00 | TSHR (0.67) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL3503427 | 1.00 | TSHR (0.67) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL10543145 | 1.00 | TSHR (0.67) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL18055 | 1.00 | TSHR (0.67) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL7762583 | 1.00 | TSHR (0.67) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL680310 | 1.00 | TSHR (0.67) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL7540354 | 1.00 | TSHR (0.67) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL953501 | 1.00 | TSHR (0.67) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL14344225 | 1.00 | TSHR (0.67) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL3503239 | 1.00 | TSHR (0.67) | TSHRDGKALMNAPAMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119463757-A | Lithium ion battery binder, preparation method thereof, lithium ion battery and electric equipment | 内江埃普诺新能源科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-113151373-B | Preparation method and application of sucrose monoester with antibacterial and antitumor activities | 武汉臻治生物科技有限公司 | 2023-07-04 | — | — | CN | claimed |
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2023-03-30 | — | — | US | claimed |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2022-06-09 | — | — | US | claimed |
| EP-3938359-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | 6th Wave Innovations Corp. (US) | 2022-01-19 | — | — | EP | claimed |
| WO-2020186077-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | 6th Wave Innovations Corp. (US) | 2020-09-17 | — | — | WO | claimed |
| CN-109966208-A | A kind of makeup removing facial mask and preparation method thereof | 湖南博隽生物医药有限公司 | 2019-07-05 | — | — | CN | claimed |
| US-9725589-B2 | Method of preparing acrylic polymers and products produced thereby | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2017-08-08 | — | — | US | claimed |
| EP-2183328-B1 | AQUEOUS PIGMENT PREPARATIONS HAVING NONIONIC ADDITIVES ON THE BASIS OF ALYL AND VINYL ETHER | CLARIANT FINANCE BVI LTD (VG) | 2014-12-24 | — | — | EP | claimed |
| US-20140336343-A1 | Method Of Preparing Acrylic Polymers And Products Produced Thereby | LUBRIZOL ADVANCED MATERIALS, INC. | 2014-11-13 | — | — | US | claimed |
| WO-2013096206-A1 | METHOD OF PREPARING ACRYLIC POLYMERS AND PRODUCTS PRODUCED THEREBY | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2013-06-27 | — | — | WO | claimed |
| US-7678870-B2 | Processable molecularly imprinted polymers | THE JOHNS HOPKINS UNIVERSITY (US) | 2010-03-16 | — | — | US | claimed |
| US-20070197746-A1 | Processable molecularly imprinted polymers | THE JOHNS HOPKINS UNIVERSITY | 2007-08-23 | — | — | US | claimed |
| EP-1733211-A4 | PROCESSABLE MOLECULARLY IMPRINTED POLYMERS | UNIV JOHNS HOPKINS (US) | 2007-05-30 | — | — | EP | claimed |
| EP-1733211-A1 | PROCESSABLE MOLECULARLY IMPRINTED POLYMERS | THE JOHNS-HOPKINS UNIVERSITY (US) | 2006-12-20 | — | — | EP | claimed |
| WO-2005103655-A1 | PROCESSABLE MOLECULARLY IMPRINTED POLYMERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2005-11-03 | — | — | WO | claimed |
| EP-1509302-A1 | SOLID MYCOCTOXIN CARRIERS | Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung (AT) | 2005-03-02 | — | — | EP | claimed |
| WO-2003101580-A1 | SOLID MYCOCTOXIN CARRIERS | Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung (AT) | 2003-12-11 | — | — | WO | claimed |
| EP-0600033-B1 | DOSAGE FORM FOR DELIVERING DRUG IN SHORT-TIME PERIOD | ALZA CORP (US) | 1995-10-25 | — | — | EP | claimed |
| US-4129711-A | COSMETICS | L'OREAL (FR) | 1978-12-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | TSHR 4448/4885DGKA 44/4885LMNA 3698/4885 |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | TSHR 4448/4885DGKA 44/4885LMNA 3698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.